The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.

由于2019年冠状病毒疾病（COVID-19）引起的健康危机震惊了世界，感染和伤亡人数超过100万人。从轻度疾病到多器官受累，尤其是急性呼吸窘迫综合征，可能存在COVID-19。在COVID-19中，心脏损伤和心律不齐，包括房颤（AF）并不少见。COVID-19具有高度传染性，对病毒的治疗仍为时过早，而且在很大程度上尚不为人所知，这使得在大流行期间对AF患者的治疗尤其具有挑战性。我们描述了COVID-19与AF之间可能的病理生理联系，以及在这种大流行期间对AF患者的治疗考虑。